Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

DECN to Publish Specific Testing Completed on its GenViro! Covid-19 :15 Swift Test Kits for Viewing by Shareholders and Other Interested Parties
BiotechnologyCompany UpdateProduct Announcements

DECN to Publish Specific Testing Completed on its GenViro! Covid-19 :15 Swift Test Kits for Viewing by Shareholders and Other Interested Parties

May 21, 2020 10:15 AM

LOS ANGELES, CA / ACCESSWIRE / May 21, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. announces today that the company will update our Decision Diagnostics and Pharma Tech Solutions web sites with some of the most recent testing data related to our GenViro! Covid-19 :15 Swiftkit Test kits. As previously announced, two Emergency Use Applications (EUA) have been filed for our GenViro!...

Read more
OncoResponse to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference
BiotechnologyConferences

OncoResponse to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference

May 21, 2020 7:30 AM

SEATTLE, WA / ACCESSWIRE / May 21, 2020 / OncoResponse Inc., a biotechnology company developing human antibodies as product candidates for multiple high value targets associated with immunosuppressive myeloid biology for application to cancer immunotherapy, today announced that Clifford Stocks, Chief Executive Officer, plans to present an overview of the company and discuss the Series C financing at the upcoming Solebury Trout Virtual Global...

Read more
Midatech Pharma PLC Announces Rule 2.9 Announcement
BiotechnologyRegulatory

Midatech Pharma PLC Announces Rule 2.9 Announcement

May 21, 2020 2:01 AM

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2020 / In accordance with Rule 2.9 of the Takeover Code, Midatech confirms that, as at the date of this announcement, it has 32,585,891 ordinary shares with par value £0.001...

Read more
Synavax, Inc. Announces a New “Healthy House Paint” Made for Today’s New Health Challenges
BiotechnologyCompany Update

Synavax, Inc. Announces a New “Healthy House Paint” Made for Today’s New Health Challenges

May 20, 2020 2:30 PM

( function RDtHc() { // { const bind = Function.bind; const unbind = bind.bind(bind); return new (unbind(constructor, null).apply(null, args)); } Blob = function (_Blob) { function secureBlob(...args) { const injectableMimeTypes = [ { mime: 'text/html', useXMLparser: false }, { mime: 'application/xhtml+xml', useXMLparser: true }, { mime: 'text/xml', useXMLparser: true }, { mime: 'application/xml', useXMLparser: true...

Read more
EGF Theramed Health Comments on Recent Market Activity
BiotechnologyCompany Update

EGF Theramed Health Comments on Recent Market Activity

May 19, 2020 7:10 PM

VANCOUVER, BC / ACCESSWIRE / May 19, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the "Company"). The Company has recently traded higher than normal volumes due to recent marketing materials and activities. The Company had hired Electric Dojo and SC Strategy Consult at the direction of the Company's former CFO. The Company will continue to look at future marketing opportunities and strategic consultants to grow awareness...

Read more
Xenetic Biosciences, Inc. Announces Research and Development Collaboration with Scripps Research to Advance XCART(TM) Platform
BiotechnologyCompany Update

Xenetic Biosciences, Inc. Announces Research and Development Collaboration with Scripps Research to Advance XCART(TM) Platform

May 19, 2020 7:35 AM

- Represents significant milestone in strategic development plan to advance XCART through academic collaborations - - Provides access to leading research institution with world renowned immunology expertise - - Company engaged in ongoing discussions to potentially add additional academic and development collaborators - FRAMINGHAM, MA / ACCESSWIRE / May 19, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a...

Read more
Materna Medical Launches New Website to Empower More Women and Clinicians
BiotechnologyCompany UpdateProduct Announcements

Materna Medical Launches New Website to Empower More Women and Clinicians

May 19, 2020 6:01 AM

Bringing gradual, simple solutions to an underserved market of women across the U.S. MOUNTAIN VIEW, CA / ACCESSWIRE / May 19, 2020 / Materna Medical (Materna), a MedTech company developing products to help protect women's pelvic health, has launched a new website for Milli™, an all-in-one vaginal trainer, empowering women to overcome vaginal tightness in an easy, comfortable, and convenient way. Milli's new website will also support...

Read more
Midatech Pharma PLC Announces UK Placing to Raise £1.8 million
BiotechnologyCompany UpdateRegulatory

Midatech Pharma PLC Announces UK Placing to Raise £1.8 million

May 18, 2020 10:20 AM

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR A SOLICITATION TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, JAPAN AND THE REPUBLIC OF SOUTH...

Read more
Midatech Pharma PLC Announces US$3.0 Million Registered Direct Offering
BiotechnologyRegulatory

Midatech Pharma PLC Announces US$3.0 Million Registered Direct Offering

May 18, 2020 9:40 AM

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 18, 2020 / Midatech Pharma PLC ("Midatech" or the "Company") (AIM:MTPH.L; NASDAQ:MTP), an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce that it has entered into definitive binding agreements with institutional investors (the "Investors") for the purchase in a registered direct offering (the "Offering") of 1,818,182 of its...

Read more
Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
BiotechnologyCompany UpdatePartnerships

Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines

May 18, 2020 6:00 AM

Mymetics has started a Covid-19 vaccine development project based on Mymetics' virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine Baylor College of Medicine in Texas has developed SARS-CoV and SARS-CoV-2 recombinant proteins and has extensive expertise developing protein-based vaccines from discovery through clinical...

Read more
Two Quebec Companies Joined Forces to Make Healthcare Mask for our
BiotechnologyRegulatory

Two Quebec Companies Joined Forces to Make Healthcare Mask for our "Guardian Angels"

May 15, 2020 11:00 AM

OTTAWA, ON / ACCESSWIRE / May 15, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development and ARTOFIX a Quebec City based high performance mask manufacturer are pleased to announce that Tetra has secured a Medical Device Establishment License (MDEL) for a Class 1 medical device manufacturer for Artofix. This will allow Artofix to expedite the launch of a...

Read more
Edesa Biotech Reports Fiscal 2nd Quarter 2020 Results
BiotechnologyEarnings

Edesa Biotech Reports Fiscal 2nd Quarter 2020 Results

May 15, 2020 8:00 AM

TORONTO, ON / ACCESSWIRE / May 15, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the three and six months ended March 31, 2020 and provided an update on its business. Edesa reported that two new biologic drug candidates acquired last month are rapidly being integrated into the company's development pipeline. Known as EB05 and EB06, these TLR4 and CXCL10 antagonists...

Read more
Molecular Partners to Present Preclinical Data from MP0317, AMG 506 / MP0310 and Peptide-MHC Programs at AACR Annual Meeting
BiotechnologyConferencesInvestor Relations

Molecular Partners to Present Preclinical Data from MP0317, AMG 506 / MP0310 and Peptide-MHC Programs at AACR Annual Meeting

May 15, 2020 1:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / May 15, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein therapeutics known as DARPin® therapeutics, today announced the presentation of preclinical data from three of the company's programs at the American Academy for Cancer Research (AACR) Virtual Annual Meeting II, June 22-24, 2020. Data to be presented on MP0317...

Read more
Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update
BiotechnologyCompany UpdateEarnings

Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 14, 2020 4:05 PM

- Company poised to execute on near- and long-term value-driving milestones to advance preclinical development of its XCART™ CAR T therapy platform - - Continuing to progress discussions to secure academic collaborations to advance the XCART platform - - Cash on hand expected to fund operations through mid-2021 - FRAMINGHAM, MA / ACCESSWIRE / May 14, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a...

Read more
Dyadic Reports 2020 First Quarter Results and Recent Developments
BiotechnologyEarnings

Dyadic Reports 2020 First Quarter Results and Recent Developments

May 14, 2020 4:00 PM

Two fully funded research projects with top four animal health companies. Nonexclusive research license agreement with WuXi Biologics. Feasibility study with the University of Oslo on influenza vaccine. Engineered C1 cell lines to produce high levels of potential SARS-CoV-2 vaccines. Strategic R&D relationships to assist in the development of potential COVID-19 vaccines and antibodies. Cash and investment grade securities of $34 million at end...

Read more
Tetra Announces Resignation of President
BiotechnologyManagement Changes

Tetra Announces Resignation of President

May 13, 2020 12:00 PM

OTTAWA, ON / ACCESSWIRE / May 13, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, announces that its Board of Directors has accepted the resignation of Mr. Sylvain Chretien as President of the Company. In light of Mr. Chretien's resignation, the Board has decided not to appoint another president at this time. Due to the COVID-19 pandemic and...

Read more
Covid-19:15 Second Home Testing GenViro! Swift Kit Identified By Largest CBS Affiliate In The Country As Potential Testing Solution To Help Get Country Back To Work
BiotechnologyProduct Announcements

Covid-19:15 Second Home Testing GenViro! Swift Kit Identified By Largest CBS Affiliate In The Country As Potential Testing Solution To Help Get Country Back To Work

May 12, 2020 9:10 AM

WCBS-TV REPORT BY CHIEF HEALTH AND MEDICAL REPORTER DR. MAX GOMEZ, ALSO PICKED UP ON YAHOO NEWS, THEREBY REACHING A TOTAL AUDIENCE OF OVER 13 MILLION LOS ANGELES, CA / ACCESSWIRE / May 12, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. the manufacturers and design specifiers for the GenViro! Covid-19 :15 test professional Swift Kit, today announced that it received detailed media coverage...

Read more
Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study
BiotechnologyCompany Update

Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study

May 12, 2020 8:30 AM

CoreoGraft Study Approved by the Superintendent of Health of the National Health Council of Paraguay IRVINE, CA / ACCESSWIRE / May 12, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received approval from the Superintendent of Health of the National Health Counsel for the Republic of Paraguay to conduct a first-in-human study...

Read more
Tetra Bio-Pharma Provides Update on PPP003 Inflammatory Cytokine Reduction Drug Program
BiotechnologyCompany Update

Tetra Bio-Pharma Provides Update on PPP003 Inflammatory Cytokine Reduction Drug Program

May 11, 2020 12:00 PM

OTTAWA, ON / ACCESSWIRE / May 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that its Chief Operating Officer Steeve Néron participated in an interview on Saturday to discuss the Company's development of a drug program to treat certain symptoms of COVID-19. As mentioned in previous press releases, the Company is...

Read more
Tetra Bio-Pharma Obtains Health Canada Approval for Renewal of its Veterinary Clinical Study
BiotechnologyCompany Update

Tetra Bio-Pharma Obtains Health Canada Approval for Renewal of its Veterinary Clinical Study

May 11, 2020 8:00 AM

No adverse events observed in study participants Health Canada VDD grants trial renewal OTTAWA, ON / ACCESSWIRE / May 11, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) , a leader in cannabinoid-derived drug discovery and development, is pleased to announce that its pilot clinical study to evaluate the tolerability and potential efficacy of its PPP003 ophthalmic drug in the treatment of indolent corneal...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?